Bupivacaine Hydrochloride In Dextrose Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 5mg/ml, 2.5mg/ml
Reference Brands: Marcaine™ Spinal, Sensorcaine-MPF Spinal
Category:
Anaesthetics
Bupivacaine Hydrochloride in Dextrose Injection is a hyperbaric spinal anesthetic used for regional anesthesia in surgeries such as C-sections and lower limb procedures, offering rapid onset and long-lasting effect.
Bupivacaine Hydrochloride In Dextrose Injection is available in Injection
and strengths such as 5mg/ml, 2.5mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bupivacaine Hydrochloride In Dextrose Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bupivacaine Hydrochloride In Dextrose Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bupivacaine Hydrochloride in Dextrose Injection is a sterile, preservative-free spinal anesthetic used for regional anesthesia in surgeries such as cesarean sections, lower abdominal, and orthopedic procedures. This hyperbaric formulation (commonly 0.75% Bupivacaine with 8.25% Dextrose) ensures controlled spread in the subarachnoid space, providing rapid onset and prolonged anesthesia. Approved in both the US (FDA) and EU (EMA), it is a trusted choice in hospital and surgical settings. Ideal for B2B distribution, tenders, and hospital supply chains, this product offers consistent demand in the anesthesiology market, making it a strong opportunity for pharmaceutical partners in regulated international markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing